April 16, 2018
DEINOVE and GREENTECH announce the launch of HEBELYS®, the first cosmetic active ingredient resulting from their collaboration
HEBELYS® is a natural active ingredient produced by the fermentation of Sphingomonas, a bacterium belonging to the DEINOVE proprietary strain library.
Various tests have demonstrated its ability to preserve youthful skin through its action on various aging factors and, in particular, on a protein involved in the process of cellular senescence.
This new active ingredient will be presented during the In-Cosmetics trade show in Amsterdam (April 17-19).
DEINOVE (Euronext Growth Paris: ALDEI), a biotechnology company that discovers, develops and produces compounds with high added value from rare bacteria, and GREENTECH, a major player in the production and distribution of active ingredients derived from biotechnology, today announced the launch of HEBELYS®, the first anti-aging active ingredient resulting from the collaboration launched in March 2017*.
HEBELYS® will be presented in the GREENTECH booth at the In-cosmetics Global trade show, which will take place in Amsterdam from April 17 to 19, 2018.
This anti-aging active ingredient is obtained by fermentation of a Sphingomonas bacterium, a rare microorganism coming from the DEINOVE strain library.
Through tests, HEBELYS® demonstrated its ability to preserve youthful skin, acting on different parameters: protection against oxidation, stimulation of collagen, elastin, and fibrillin synthesis. HEBELYS® has, in particular, a significant and proven action on the expression of the p16 IINK4A protein, a key factor of premature cellular aging.
Under the effect of HEBELYS®, the skin is protected, regaining density, suppleness, and elasticity: younger-looking.
HEBELYS® is the first active ingredient resulting from the collaboration between DEINOVE and GREENTECH, fruit of the alliance of complementary skills: DEINOVE selected the strain, developed the production process to achieve optimal fermentation performances, and supervised the in vitro tests intended to characterize the extract; GREENTECH developed the formulation process, and validated the stability and the safety, as well as the efficiency, by additional ex vivo tests.
HEBELYS® will be marketed effectively by GREENTECH.
Jean-Yves Berthon, CEO of GREENTECH, stated: “This first collaboration is a real success. HEBELYS® is a truly great active ingredient, fully in line with our catalog and our ambition to offer the cosmetic industry high-tech active ingredients.”
Emmanuel PETIOT, CEO of DEINOVE added: “The joint work of both teams has been very rewarding. We are proud to have responded to GREENTECH’s expectations in terms of innovation and achieved a commercial product so quickly. We intend to continue in this direction.”